fluoxetine has been researched along with Tobacco Use Disorder in 3 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Tobacco Use Disorder: Tobacco used to the detriment of a person's health or social functioning. Tobacco dependence is included.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The symptom of "diminished interest or pleasure" in rewarding stimuli is an affective symptom of nicotine and amphetamine withdrawal, and a core symptom of depression." | 3.71 | Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats. ( Harrison, AA; Liem, YT; Markou, A, 2001) |
| " Dosing order was determined randomly and counterbalanced." | 2.70 | Subjective and discriminative stimulus effects of two de-nicotinized cigarettes with different tar yields. ( Downey, KK; Schuh, KJ; Schuh, LM; Stamat, HM, 2001) |
| "Patients with major depressive disorder (DSM-IV) who showed favorable treatment response to venlafaxine (mean +/- SD dose = 116." | 1.35 | Time to rehospitalization in patients with major depressive disorder taking venlafaxine or fluoxetine. ( Chen, MC; Lane, HY; Lin, CH; Lin, CY; Lin, KS, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, CH | 1 |
| Lin, KS | 1 |
| Lin, CY | 1 |
| Chen, MC | 1 |
| Lane, HY | 1 |
| Schuh, LM | 1 |
| Stamat, HM | 1 |
| Downey, KK | 1 |
| Schuh, KJ | 1 |
| Harrison, AA | 1 |
| Liem, YT | 1 |
| Markou, A | 1 |
1 trial available for fluoxetine and Tobacco Use Disorder
| Article | Year |
|---|---|
Subjective and discriminative stimulus effects of two de-nicotinized cigarettes with different tar yields.
Topics: Adult; Blood Pressure; Female; Fluoxetine; Heart Rate; Humans; Male; Middle Aged; Nicotine; Selectiv | 2001 |
2 other studies available for fluoxetine and Tobacco Use Disorder
| Article | Year |
|---|---|
Time to rehospitalization in patients with major depressive disorder taking venlafaxine or fluoxetine.
Topics: Adult; Combined Modality Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Diagnostic | 2008 |
Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats.
Topics: Aminopyridines; Amphetamine; Amphetamine-Related Disorders; Animals; Body Weight; Brain; Depression; | 2001 |